Oriza, China Minsheng Investment Lead $76M Round In Chinese Voice Recognition Firm AISpeech Technology
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes Life Science
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center Life Science